<DOC>
	<DOCNO>NCT00748371</DOCNO>
	<brief_summary>Aspirin show beneficial patient certain disease coronary artery disease stroke . We investigate aspirin work regulate platelet thromboxane time different dos . We hope find best dose aspirin and/or medication help people risk heart attack stroke .</brief_summary>
	<brief_title>Loss Effect Aspirin Platelet Aggregation During Chronic Administration</brief_title>
	<detailed_description>purpose study well understand mechanism failure daily aspirin administration prevent cardiovascular event risk individual . We seek describe effect chronic aspirin administration vary dos platelet aggregation . This help define mechanisms aspirin failure pursue possible alternative therapy patient fail respond aspirin therapy . We hypothesize ( 1 ) inhibition aspirin ( ASA ) ex vivo-induced platelet aggregation varies predictable time dose dependent manner , ( 2 ) thromboxane prostacyclin production inhibit ASA dose-dependent manner remain relatively constant time maximal inhibition occur , ( 3 ) granule secretion platelet induce aggregation inhibit aspirin acutely effect persist chronic administration high dos .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Males Age 1840 year Nonsmokers ASA/NSAID use previous 14 day . Evidence ASA/NSAID use within previous 14 day baseline visit base investigator interpretation platelet aggregation platelet secretion study . History chronic NSAID use . Currently take NSAIDs , corticosteroid , anticoagulant . History coronary artery disease , myocardial infarction , coronary artery bypass grafting , percutaneous angioplasty , diabetes mellitus stroke . History gastric , duodenal , esophageal ulcer serious gastrointestinal bleed . History frequent headache , pain syndrome , condition require frequent use analgesic . History adverse reaction ASA . Initial platelet count &lt; 100K/µl &gt; 500K/µl . Initial hematocrit &lt; 35 % &gt; 50 % . Weight le 110 pound .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>platelet aggregation</keyword>
	<keyword>granule secretion</keyword>
	<keyword>thromboxane production</keyword>
	<keyword>prostacyclin production</keyword>
</DOC>